Aligos Therapeutics (ALGS) Treasury Shares (2019 - 2026)
Aligos Therapeutics' (ALGS) quarterly Treasury Shares came in at $80045.0 in Q1 2026, up 363.65% YoY from $17264.0 in Q1 2025, and up 4.24% on a QoQ basis from $76786.0 in Q4 2025.
Aligos Therapeutics (ALGS) Treasury Shares (2019 - 2026) Analysis & Trends
Aligos Therapeutics (ALGS) has 8 years of Treasury Shares data on file, last reported at $80045.0 in Q1 2026.
- Quarterly Treasury Shares rose 363.65% year-over-year to $80045.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $80045.0 (up 363.65% YoY) and the FY2025 annual result came in at $76786.0, up 1523.73% from the prior year.
- Treasury Shares grew to $80045.0 in Q1 2026, from $76786.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $154580.0 in Q1 2024 to a low of $3717.0 in Q2 2022.
- A 5-year average of $57767.3 and a median of $21238.0 in 2022 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2022 — Treasury Shares plunged 99.94% — and 2025, when it jumped 1635.4%.
- Tracing ALGS's Treasury Shares over 5 years: stood at $3717.0 in 2022, then surged by 44.26% to $5362.0 in 2023, then retreated by 11.81% to $4729.0 in 2024, then surged by 1523.73% to $76786.0 in 2025, then grew by 4.24% to $80045.0 in 2026.
- The last three Treasury Shares figures came in at $80045.0 (Q1 2026), $76786.0 (Q4 2025), and $76861.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Aligos Therapeutics | 68.90 Mn | 38.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 80,388.00 |
| Jun 30, 2026 | 80,388.00 |
| Mar 31, 2026 | 80,045.00 |
| Mar 31, 2026 | 80,045.00 |
| Dec 31, 2025 | 76,786.00 |
| Dec 31, 2025 | 76,786.00 |
| Sep 30, 2025 | 76,861.00 |
| Sep 30, 2025 | 76,861.00 |
| Jun 30, 2025 | 17,264.00 |
| Jun 30, 2025 | 17,264.00 |
| Mar 31, 2025 | 17,264.00 |
| Mar 31, 2025 | 17,264.00 |
| Dec 31, 2024 | 4,729.00 |
| Dec 31, 2024 | 4,729.00 |
| Sep 30, 2024 | 4,429.00 |
| Sep 30, 2024 | 4,429.00 |
| Jun 30, 2024 | 154,580.00 |
| Jun 30, 2024 | 154,580.00 |
| Mar 31, 2024 | 154,580.00 |
| Mar 31, 2024 | 154,580.00 |